The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 27, 2015
Filed:
Jan. 29, 2009
Applicants:
Tatsuhiro Ishida, Tokushima, JP;
Hiroshi Kiwada, Tokushima, JP;
Inventors:
Tatsuhiro Ishida, Tokushima, JP;
Hiroshi Kiwada, Tokushima, JP;
Assignees:
The University of Tokushima, Tokushima-shi, Tokushima, JP;
Taiho Pharmaceutical Co. Ltd., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 31/282 (2006.01); A61K 31/4412 (2006.01); A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/53 (2006.01); A61K 31/555 (2006.01);
U.S. Cl.
CPC ...
A61K 31/282 (2013.01); A61K 9/127 (2013.01); A61K 9/1271 (2013.01); A61K 9/1272 (2013.01); A61K 31/4412 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/53 (2013.01); A61K 31/555 (2013.01);
Abstract
An object of the present invention is to further enhance the antitumor effect when oxaliplatin is administered in combination with a combination drug containing tegafur, gimeracil and oteracil potassium. According to the present invention, by using oxaliplatin encapsulated in a liposome preparation, combination therapy of oxaliplatin plus a combination drug containing tegafur, gimeracil and oteracil potassium, is revealed to show remarkably enhanced antitumor effect without increasing side effects.